 |
 |

Potential Harmful Effect of Iodinated Intravenous Contrast Medium on the Clinical Course of Mild Acute Pancreatitis
Ramón Carmona-Sánchez, MD;
Luis Uscanga, MD;
Paulina Bezaury-Rivas, MD;
Guillermo Robles-Díaz, MD;
Jorge Suazo-Barahona, MD;
Florencia Vargas-Vorácková, MD
Arch Surg. 2000;135:1280-1284.
Hypothesis A worse clinical outcome might be expected in patients with acute pancreatitis (AP) who receive intravenous contrast medium for a nondynamic contrast-enhanced computed tomographic (CECT) study early during hospital admission.
Design Cohort analytic study.
Setting Tertiary care center.
Patients Of 126 patients with mild AP, 52 patients underwent CECT to establish AP diagnosis (group 1), and the remaining 74 did not (group 2).
Main Outcome Measures Survival and development of local or systemic complications during the hospital stay. Potential confounders were demographic, clinical, and biochemical data, as well as therapeutic measures. The Atlanta classification was used to define local and systemic complications.
Results Mean age, etiology of AP, prognostic score on admission, and pharmacologic treatment were similar between groups. Local and systemic complications were more frequently observed in patients who underwent CECT (odds ratio, 11.4; 95% confidence interval, 2.0-64.8; P = .008). Six patients, all in group 1, developed a pancreatic abscess (odds ratio, 20.8; P = .004). In 5 of them, a second CECT showed more severe AP changes. The association between CECT and abscess development was more apparent in patients with a body mass index of 25 or more and/or nasogastric suction. Six patients in group 1 and 1 in group 2 had systemic complications (odds ratio, 9.5; P = .01). There were no deaths.
Conclusions The observed increased incidence of local and systemic complications in patients with mild AP who undergo CECT, particularly in those with a body mass index of 25 or more, suggests a potentially harmful effect of intravenous contrast medium. Until this issue is clarified, it seems reasonable to restrict the use of dynamic CECT to patients with severe AP, protracted clinical course, or suspected local septic complication.
From the Departments of Gastroenterology (Drs Carmona-Sánchez, Uscanga, Robles-Díaz, Suazo-Barahona, and Vargas-Vorácková) and Radiology (Dr Bezaury-Rivas), Instituto Nacional de la Nutrición Salvador Zubirán, Tlalpan, México.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(11):1373-1374.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Two cases of iodixanol-induced pancreatitis
Kheda and Szerlip
NDT Plus 2008;1:296-299.
FULL TEXT
Pancreatic Perfusion: Noninvasive Quantitative Assessment with Dynamic Contrast-enhanced MR Imaging without and with Secretin Stimulation in Healthy Volunteers--Initial Results
Bali et al.
Radiology 2008;247:115-121.
ABSTRACT
| FULL TEXT
Echo enhanced ultrasound: a new valid initial imaging approach for severe acute pancreatitis
Rickes et al.
Gut 2006;55:74-78.
ABSTRACT
| FULL TEXT
Identification of Admission Values Predictive of Complicated Acute Alcoholic Pancreatitis
Dauphine et al.
Arch Surg 2004;139:978-982.
ABSTRACT
| FULL TEXT
Iodinated contrast media induce neutrophil apoptosis through a mitochondrial and caspase mediated pathway
Fanning et al.
Br. J. Radiol. 2002;75:861-873.
ABSTRACT
| FULL TEXT
Predicting the Severity of Acute Pancreatitis by Rapid Measurement of Trypsinogen-2 in Urine
Lempinen et al.
Clin. Chem. 2001;47:2103-2107.
ABSTRACT
| FULL TEXT
Does Early Contrast-Enhanced CT Worsen the Course of Acute Pancreatitis?
JWatch Gastroenterology 2001;2001:13-13.
FULL TEXT
|